vs
Elastic N.V.（ESTC）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Elastic N.V.的季度营收约是Orthofix Medical Inc.的1.9倍（$423.5M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -12.1%，领先11.1%），Elastic N.V.同比增速更快（15.9% vs 2.0%），Elastic N.V.自由现金流更多（$26.0M vs $16.8M），过去两年Elastic N.V.的营收复合增速更高（13.6% vs 8.0%）
Elastic是荷美合资软件企业，2012年成立于荷兰阿姆斯特丹，运营总部分设于荷兰及美国加利福尼亚州旧金山市，于纽交所上市。公司提供企业级搜索、可观测性、网络安全平台，可支持用户实现大规模数据搜索分析、系统性能监测及异常检测。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ESTC vs OFIX — 直观对比
营收规模更大
ESTC
是对方的1.9倍
$219.9M
营收增速更快
ESTC
高出13.9%
2.0%
净利率更高
OFIX
高出11.1%
-12.1%
自由现金流更多
ESTC
多$9.2M
$16.8M
两年增速更快
ESTC
近两年复合增速
8.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $423.5M | $219.9M |
| 净利润 | $-51.3M | $-2.2M |
| 毛利率 | 75.9% | 71.1% |
| 营业利润率 | -1.9% | 0.2% |
| 净利率 | -12.1% | -1.0% |
| 营收同比 | 15.9% | 2.0% |
| 净利润同比 | -101.5% | 92.4% |
| 每股收益（稀释后） | $-0.48 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESTCOFIX
| Q4 25 | $423.5M | $219.9M | ||
| Q3 25 | $415.3M | $205.6M | ||
| Q2 25 | $388.4M | $203.1M | ||
| Q1 25 | $382.1M | $193.6M | ||
| Q4 24 | $365.4M | $215.7M | ||
| Q3 24 | $347.4M | $196.6M | ||
| Q2 24 | $335.0M | $198.6M | ||
| Q1 24 | $328.0M | $188.6M |
净利润ESTCOFIX
| Q4 25 | $-51.3M | $-2.2M | ||
| Q3 25 | $-24.6M | $-22.8M | ||
| Q2 25 | $-16.4M | $-14.1M | ||
| Q1 25 | $-17.1M | $-53.1M | ||
| Q4 24 | $-25.4M | $-29.1M | ||
| Q3 24 | $-49.2M | $-27.4M | ||
| Q2 24 | $-41.1M | $-33.4M | ||
| Q1 24 | $176.1M | $-36.0M |
毛利率ESTCOFIX
| Q4 25 | 75.9% | 71.1% | ||
| Q3 25 | 76.7% | 72.2% | ||
| Q2 25 | 74.8% | 68.7% | ||
| Q1 25 | 74.6% | 62.8% | ||
| Q4 24 | 74.5% | 69.0% | ||
| Q3 24 | 73.6% | 68.7% | ||
| Q2 24 | 73.8% | 67.8% | ||
| Q1 24 | 74.2% | 67.5% |
营业利润率ESTCOFIX
| Q4 25 | -1.9% | 0.2% | ||
| Q3 25 | -2.3% | -8.3% | ||
| Q2 25 | -3.1% | -7.9% | ||
| Q1 25 | -1.2% | -25.2% | ||
| Q4 24 | -1.2% | -5.3% | ||
| Q3 24 | -9.7% | -9.6% | ||
| Q2 24 | -13.6% | -12.5% | ||
| Q1 24 | -8.1% | -15.6% |
净利率ESTCOFIX
| Q4 25 | -12.1% | -1.0% | ||
| Q3 25 | -5.9% | -11.1% | ||
| Q2 25 | -4.2% | -6.9% | ||
| Q1 25 | -4.5% | -27.4% | ||
| Q4 24 | -7.0% | -13.5% | ||
| Q3 24 | -14.2% | -13.9% | ||
| Q2 24 | -12.3% | -16.8% | ||
| Q1 24 | 53.7% | -19.1% |
每股收益（稀释后）ESTCOFIX
| Q4 25 | $-0.48 | $-0.05 | ||
| Q3 25 | $-0.23 | $-0.57 | ||
| Q2 25 | $-0.15 | $-0.36 | ||
| Q1 25 | $-0.16 | $-1.35 | ||
| Q4 24 | $-0.25 | $-0.76 | ||
| Q3 24 | $-0.48 | $-0.71 | ||
| Q2 24 | $-0.35 | $-0.88 | ||
| Q1 24 | $1.69 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $82.0M |
| 总债务越低越好 | $570.3M | — |
| 股东权益账面价值 | $891.1M | $450.0M |
| 总资产 | $2.5B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.64× | — |
8季度趋势，按日历期对齐
现金及短期投资ESTCOFIX
| Q4 25 | $1.4B | $82.0M | ||
| Q3 25 | $1.5B | $62.9M | ||
| Q2 25 | $1.4B | $65.6M | ||
| Q1 25 | $584.0M | $58.0M | ||
| Q4 24 | $658.5M | $83.2M | ||
| Q3 24 | $594.9M | $30.1M | ||
| Q2 24 | $1.1B | $26.4M | ||
| Q1 24 | $526.9M | $27.0M |
总债务ESTCOFIX
| Q4 25 | $570.3M | — | ||
| Q3 25 | $570.0M | $157.2M | ||
| Q2 25 | $569.7M | $157.0M | ||
| Q1 25 | $569.4M | $156.9M | ||
| Q4 24 | $569.2M | $157.0M | ||
| Q3 24 | $568.9M | $118.5M | ||
| Q2 24 | $568.6M | $118.0M | ||
| Q1 24 | $568.3M | $118.2M |
股东权益ESTCOFIX
| Q4 25 | $891.1M | $450.0M | ||
| Q3 25 | $971.4M | $442.5M | ||
| Q2 25 | $927.2M | $458.3M | ||
| Q1 25 | $859.1M | $458.3M | ||
| Q4 24 | $811.5M | $503.1M | ||
| Q3 24 | $759.4M | $525.9M | ||
| Q2 24 | $738.2M | $546.0M | ||
| Q1 24 | $707.8M | $570.3M |
总资产ESTCOFIX
| Q4 25 | $2.5B | $850.6M | ||
| Q3 25 | $2.5B | $832.6M | ||
| Q2 25 | $2.6B | $837.2M | ||
| Q1 25 | $2.3B | $823.1M | ||
| Q4 24 | $2.2B | $893.3M | ||
| Q3 24 | $2.2B | $867.9M | ||
| Q2 24 | $2.2B | $882.0M | ||
| Q1 24 | $2.1B | $906.0M |
负债/权益比ESTCOFIX
| Q4 25 | 0.64× | — | ||
| Q3 25 | 0.59× | 0.36× | ||
| Q2 25 | 0.61× | 0.34× | ||
| Q1 25 | 0.66× | 0.34× | ||
| Q4 24 | 0.70× | 0.31× | ||
| Q3 24 | 0.75× | 0.23× | ||
| Q2 24 | 0.77× | 0.22× | ||
| Q1 24 | 0.80× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $26.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 6.1% | 7.6% |
| 资本支出强度资本支出/营收 | 0.1% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $302.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ESTCOFIX
| Q4 25 | $26.6M | $27.7M | ||
| Q3 25 | $104.8M | $12.4M | ||
| Q2 25 | $87.0M | $11.6M | ||
| Q1 25 | $88.1M | $-18.4M | ||
| Q4 24 | $38.4M | $23.7M | ||
| Q3 24 | $52.8M | $11.7M | ||
| Q2 24 | $60.9M | $9.0M | ||
| Q1 24 | $52.4M | $-18.6M |
自由现金流ESTCOFIX
| Q4 25 | $26.0M | $16.8M | ||
| Q3 25 | $104.2M | $2.5M | ||
| Q2 25 | $84.9M | $4.5M | ||
| Q1 25 | $87.3M | $-25.1M | ||
| Q4 24 | $37.7M | $15.2M | ||
| Q3 24 | $52.0M | $6.3M | ||
| Q2 24 | $60.1M | $-360.0K | ||
| Q1 24 | $51.3M | $-29.1M |
自由现金流率ESTCOFIX
| Q4 25 | 6.1% | 7.6% | ||
| Q3 25 | 25.1% | 1.2% | ||
| Q2 25 | 21.8% | 2.2% | ||
| Q1 25 | 22.8% | -13.0% | ||
| Q4 24 | 10.3% | 7.0% | ||
| Q3 24 | 15.0% | 3.2% | ||
| Q2 24 | 17.9% | -0.2% | ||
| Q1 24 | 15.6% | -15.4% |
资本支出强度ESTCOFIX
| Q4 25 | 0.1% | 4.9% | ||
| Q3 25 | 0.2% | 4.8% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.2% | 3.5% | ||
| Q4 24 | 0.2% | 4.0% | ||
| Q3 24 | 0.2% | 2.7% | ||
| Q2 24 | 0.3% | 4.7% | ||
| Q1 24 | 0.3% | 5.6% |
现金转化率ESTCOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.30× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESTC
| Self Managed Subscription | $192.0M | 45% |
| Saa S Self Managed Annual | $156.9M | 37% |
| Saa S Self Managed Monthly | $48.8M | 12% |
| Professional Services | $25.8M | 6% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
